Takuya Owari

4PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersRadiation therapyHealth policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 15, 2023
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study.

Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama

|Sep 20, 2022
Local dose (biologically effective dose ≥180 Gy2) is an important predictor of biochemical recurrence in patients undergoing low-dose-rate brachytherapy.

Nobumichi Tanaka, Yasushi Nakai, Isao Asakawa

|Jan 24, 2022
Clinical and emotional factors for the acceptance or refusal of deceased-donor kidney transplantation in patients on waiting lists during the coronavirus disease 2019 pandemic.

Shunta Hori, Mitsuru Tomizawa, Tatsuo Yoneda

|Nov 11, 2021
Impact of neoadjuvant androgen deprivation therapy on postimplant prostate D90 and prostate volume after low-dose-rate brachytherapy for localized prostate cancer.

Takuya Owari, Nobumichi Tanaka, Yasushi Nakai

Pageof 1